ERIVEDGE (vismodegib) for Basal Cell Carcinoma - Cancer Therapy Advisor

ERIVEDGE (vismodegib) for Basal Cell Carcinoma

Slideshow

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

This slideshow reviews drug information for ERIVEDGE (vismodegib), indicated for basal cell carcinoma.

Table of Contents

Slide 3: Indication, Dosage, and Administration
Slide 7: Use in Specific Populations
Slide 10: Clinical Pharmacology
Slide 14: Warnings and Precautions
Slide 19: Clinical Safety and Efficacy
Slide 25: Drug Storage and Supply
Slide 28: References

Next hm-slideshow in Skin Cancer